Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
The British Journal of Dermatology|August 6, 2013
Nickel allergy following European Union regulation in Denmark, Germany, Italy and the U.KS Garg, J P Thyssen, W Uter, et al.Occupational Medicine (Oxford, England)|June 11, 2022
Skin and respiratory ill-health attributed to occupational face mask useM J Seed, K Fowler, L Byrne, et al.The British Journal of Dermatology|August 14, 2002
Type-IV hypersensitivity to betamethasone valerate and clobetasol propionate: results of a multicentre studyS Sommer, S M Wilkinson, J S C English, et al.The British Journal of Dermatology|November 28, 2008
Guideline for the diagnosis and management of vitiligoD J Gawkrodger, A D Ormerod, L Shaw, et al.Human Genetics|February 18, 2003
Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areataR Tazi-Ahnini, M J Cork, D Wengraf, et al.The British Journal of Dermatology|February 18, 2003
The British standard series of contact dermatitis allergens: validation in clinical practice and value for clinical governanceJ E R Britton, S M Wilkinson, J S C English, et al.The British Journal of Dermatology|July 12, 2008
The autoimmune regulator gene (AIRE) is strongly associated with vitiligoR Tazi-Ahnini, A J G McDonagh, D A Wengraf, et al.The British Journal of Dermatology|January 3, 2013
The angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysisM Patwardhan, V Pradhan, L H Taylor, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2012
Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligoM W Kroon, E Helen Kemp, B S Wind, et al.The British Journal of Dermatology|August 7, 2012
Guidelines for the management of vitiligo: the European Dermatology Forum consensusA Taieb, A Alomar, M Böhm, et al.Pageof 13